1)厚生労働省:自殺・うつ病等対策プロジェクトチームとりまとめについて. https://www.mhlw.go.jp/seisaku/2010/07/03.html(2022年7月11日閲覧)
2)三木治:プライマリ・ケアにおけるうつ病の実態と治療.心身医学 42(9) : 585-591, 2002.
3)Park LT, et al : Depression in the primary care setting. N Engl J Med 380(6) : 559-568, 2019. PMID 30726688
4)Kotlyar M, et al : Update on drug-induced depression in the elderly. Am J Geriatr Pharmacother 3(4) : 288-300, 2005. PMID 16503326
5)Patten SB et al : Drug-induced depression ; a systematic review to inform clinical practice. Psychother Psychosom 73(4) : 207-215, 2004. PMID 15184715
6)Riemer TG, et al : Do β-blockers cause depression? ; systematic review and meta-analysis of psychiatric adverse events during β-blocker therapy. Hypertension 77(5) : 1539-1548, 2021. PMID 33719510
blocker exposure as a risk factor for depression. Can J Psychiatry 41(8) : 537-538,1996. PMID 8899245
8)Lee MC, et al : Statin use and depression risk ; a systematic review and meta-analysis. J Affect Disord 282 : 308-315, 2021. PMID 33421857
9)Molero Y, et al : Associations between statin use and suicidality, depression, anxiety, and seizures ; a Swedish total-population cohort study. Lancet Psychiatry 7(11) : 982-990, 2020. PMID 33069320